Infigo Clinical Research

What Infigo Clinical Research does

Infigo Clinical Research is a Florida-based, physician-led independent clinical trial site network conducting Phase 1 through Phase 4 studies on behalf of pharmaceutical and medical device sponsors. The company operates from a headquarters in Sanford, Florida, and delivers patient care and study procedures through an integrated network of 20+ affiliated clinics across North and Central Florida, supported by partnerships with HCA Lake Monroe Hospital, Orlando Health South Hospital, AdventHealth Altamonte Springs, Lake Surgical Center, Pure Life Renal, and accredited radiology facilities. Its multi-specialty investigator team spans nephrology, rheumatology, gastroenterology, urology, internal medicine, and physiatry, with board-certified physicians contributing over 100 years of combined medical expertise across the conduct of more than 100 clinical trials.

The platform's core service offering is the execution of clinical trials across therapeutic areas including chronic kidney disease, diabetes, hypertension, heart failure, lupus, fatty liver disease, inflammatory bowel disease, dialysis, weight loss, gout, and medical device studies. Specialized on-site capabilities include an 18-bed dialysis facility (Pure Life Renal with 7 regional HD centers), an infusion center, endoscopy center, ECG collection with on-call cardiologist oversight, intensive pharmacokinetic (PK) sample collection via IV lines, and radiology imaging (MRI, CT, ultrasound, X-ray) through partner facilities. Telemedicine visit infrastructure enables remote patient participation and continuity of operations during health crises. Multilingual staff communication in English, Spanish, French, Haitian Creole, Urdu, and Arabic supports patient health literacy and diverse community enrollment.

The business model is B2B professional services: pharmaceutical sponsors (named partners include Pfizer, GSK, AstraZeneca, Merck, and Vertex Pharmaceuticals) contract Infigo to conduct trials, funding the research directly. Patient participation is free, with no insurance required, and volunteers may receive time and travel reimbursement. The company is privately held and founder-owned, led by CEO Dr. Sayed M. Husain, a board-certified nephrologist. No external investors, private equity, or parent company are disclosed. Revenue is generated through study fees and per-trial economics, with no public pricing, SaaS, or AI-software component.

Name

Infigo Clinical Research

Legal name

Infigo Clinical Research

Website

https://infigoresearch.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Infigo Clinical Research is a privately held, physician-led clinical trial site network in Sanford, Florida that conducts Phase 1-4 trials for pharmaceutical sponsors across 20+ North and Central Florida clinics, with specialized dialysis, infusion, and diagnostic capabilities.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Medical and Diagnostic Laboratories (6215), Scientific Research and Development Services (5417), Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

Keywords

• Clinical trial services
• Clinical research site network
• Multi-therapeutic trials
• Patient recruitment services
• Pharmacokinetic sampling

Headquarters

HQ city

Sanford

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Clinical Trial Conduct Services: Revenue generated by conducting Phase 1-4 clinical trials for pharmaceutical company sponsors. Services include patient recruitment, study execution, data collection, and regulatory compliance. No cost to patients - sponsors fund the research.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Infigo Clinical Research operates a multi-therapeutic clinical trial site network that conducts Phase 1-4 clinical trials for pharmaceutical sponsors across 20+ clinics in North and Central Florida. The company recruits patients and healthy volunteers, executes study protocols, and delivers diagnostic, infusion, ECG, endoscopy, radiology, and dialysis services required by trial protocols. Sponsors including Pfizer, GSK, AstraZeneca, Merck, and Vertex contract Infigo to perform clinical research, while participants join free of charge.

Product overview

Infigo Clinical Research operates as a multi-therapeutic clinical trial site network providing comprehensive research services. The core offering consists of Phase 1-4 clinical trials across multiple therapeutic areas including chronic kidney disease, diabetes, hypertension, heart failure, lupus, fatty liver, and inflammatory bowel diseases. The platform delivers services through a network of 20+ clinic locations throughout North and Central Florida, supported by diagnostic capabilities including endoscopy, radiology imaging, ECG services, and infusion center facilities. Patient-facing services include research consultations, telemedicine visits, and blood pressure checks, while specialized dialysis services with 18-bed capacity support renal clinical trials. The company collaborates with pharmaceutical partners including Pfizer, GSK, AstraZeneca, and Vertex to conduct clinical research.

Differentiator

Problem solved

Functional benefit

Products and services

• Phase 1-4 Clinical Trials Comprehensive clinical trial conduct services spanning Phase 1 through Phase 4, covering multiple therapeutic areas with experience in interventional and observational study designs for pharmaceutical sponsors.
• Telemedicine Visits Virtual clinical trial visits enabling remote patient monitoring and care delivery, with seamless transition capability to virtual operations during health crises for enrolled trial participants.
• Research Consultation 30-minute consultation service providing prospective patients with information about clinical trials and research participation options.
• Introduction to Clinical Research Virtual 30-minute question and answer session allowing prospective participants to learn about clinical research from any location.
• Intensive PK Sample Collection Pharmacokinetic sample collection service utilizing intravenous lines for intensive sampling within tight time frames to support clinical trial pharmacokinetic assessments.
• Infusion Center Services On-site infusion services administered by infusion specialists to meet clinical trial protocol requirements for investigational and approved infusion therapies.
• Endoscopy Center Services State-of-the-art endoscopy facilities with experience in capturing live videography during procedures and accommodating scheduling requests for clinical trial protocols.
• ECG Services On-site ECG collection, review, and interpretation with on-call cardiologist oversight for immediate decision-making during clinical trial visits.
• Dialysis Services 18-bed dialysis facility offering hemodialysis, peritoneal, and home dialysis clinical trial capabilities with first, second, and third shift availability through Pure Life Renal and 7 regional HD centers.
• Radiology Imaging Services MRI, CT, ultrasound, and X-ray imaging services obtained through partnerships with accredited radiology facilities to satisfy clinical trial protocol imaging requirements.
• Chronic Kidney Disease Trials Clinical trials focused on chronic kidney disease management and treatment, including the Vertex Amplitude Study for APOL1-mediated proteinuric kidney disease.
• Diabetes and Hypertension Trials Clinical trials investigating diabetes treatments and management strategies, alongside trials for blood pressure management and hypertension treatments.
• Lupus and Rheumatoid Arthritis Trials Clinical trials for systemic lupus erythematosus and rheumatoid arthritis treatment.
• Heart Failure and Fatty Liver Trials Clinical trials focused on heart failure treatment and management, alongside trials investigating fatty liver disease treatments.
• IBS, Crohn's, and Ulcerative Colitis Trials Clinical trials for inflammatory bowel diseases including irritable bowel syndrome, Crohn's disease, and ulcerative colitis.
• Weight Loss and Gout Trials
• Medical Device Studies
• Women's and Men's Health Trials

Quantifiable outcome

• Over 100 clinical trials completed across Phase I-IV
• +1 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eleven partnerships are on record, tiered core and major.

• PfizercoreStrategic or Co-development PartnerCollaborating pharmaceutical organization for clinical trial sponsorship. Pfizer contracts with Infigo to conduct clinical trials for drug development in various therapeutic areas.
• GSK (GlaxoSmithKline)coreStrategic or Co-development PartnerCollaborating pharmaceutical organization for clinical trial sponsorship. GSK partners with Infigo for Phase 1-4 clinical trials.
• AstraZenecacoreStrategic or Co-development PartnerCollaborating pharmaceutical organization for clinical trial sponsorship. AstraZeneca works with Infigo on clinical research studies.
• MerckcoreStrategic or Co-development PartnerCollaborating pharmaceutical organization for clinical trial sponsorship. Merck partners with Infigo for clinical research studies.
• Vertex PharmaceuticalscoreStrategic or Co-development PartnerCollaborating pharmaceutical organization for clinical trial sponsorship. Vertex Pharmaceuticals conducts studies with Infigo including the Amplitude Study for APOL1-mediated proteinuric kidney disease.
• HCA Lake Monroe HospitalmajorStrategic or Co-development PartnerLocal hospital affiliation providing ability to accommodate inpatient clinical trials, renal biopsies, and advanced imaging needs.
• Orlando Health South HospitalmajorStrategic or Co-development PartnerRegional hospital partnership for inpatient clinical trial support and advanced medical imaging services.
• AdventHealth Altamonte SpringsmajorStrategic or Co-development PartnerHospital affiliation providing additional inpatient clinical trial and advanced imaging capabilities.
• Pure Life Renal + 7 Regional HD CenterscoreStrategic or Co-development Partner18-bed dialysis facility with ability to accommodate Hemodialysis, Peritoneal and Home dialysis clinical trials. First, second, and third shift sessions available. Home Hemodialysis Certified facility.
• Lake Surgical CentermajorStrategic or Co-development PartnerOutpatient surgical center partnership for biopsies and endoscopy testing procedures.
• Accredited Radiology Facilities (MRI/CT/US/X-Ray)majorTechnology or IntegrationPartnered with accredited facilities to obtain any radiology imaging required by clinical trial protocols.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Medpace: Medpace is a mid-to-large global CRO with strong site-management relationships that competes for the same sponsor Phase 2-4 trials that Infigo conducts.
• IQVIA (Site Solutions / site network): IQVIA is the largest global CRO/SMO, with an extensive site network and patient-recruitment infrastructure that competes with Infigo for sponsor trials and sets industry-standard operational expectations.
• Syneos Health: Syneos is a global CRO with an integrated site-network component (formerly INC Research), providing end-to-end trial conduct that competes head-to-head with independent site networks like Infigo.

Direct peers

• Accel Research Sites: Accel is a multi-site clinical research organization operating across the U.S. with Phase 1-4 trial capabilities across multiple therapeutic areas, directly comparable to Infigo's site-network, multi-TA model.
• Flourish Research: Flourish is an integrated clinical research site organization with multi-specialty therapeutic coverage, operating similarly to Infigo in serving as a regional/multi-region site for pharma-sponsored Phase 1-4 trials.
• Velocity Clinical Research: Velocity is a multi-therapeutic, integrated clinical research site network conducting Phase 1-4 trials across numerous U.S. locations, making it a direct comparable in operating model, sponsor relationships, and therapeutic-area breadth to Infigo.
• Elligo Health Research: Elligo operates a decentralized site network that brings clinical trials into community physician practices, mirroring Infigo's model of leveraging a network of clinics and community-based recruitment for sponsor trials.
• DM Clinical Research: DM Clinical operates a multi-site clinical research network with Phase 1-4 capabilities across multiple therapeutic areas including chronic disease and renal indications, comparable in operating model to Infigo.
• Javara Research: Javara is an Integrated Research Organization partnering with healthcare practices to embed clinical trial capacity, closely aligned with Infigo's model of using affiliated clinics to deliver sponsor trials across therapeutic areas.

Others

• Clincierge: Clincierge provides patient logistics and reimbursement services to clinical trial sites and sponsors — an adjacent service provider in the clinical-trial ecosystem that often works alongside site networks like Infigo.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/InfigoClinicalResearch
• LinkedInlinkedin.com/company/infigoresearch
• Instagraminstagram.com/infigoclinicalresearch

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Infigo Clinical Research